Blog

Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University Bacteriophage therapy is one potential strategy to treat antimicrobial resistant or persistent bacterial infections, and the year 2021 marked…

Antibiotic-resistant infections are a particular concern with large-scale use of antibiotics to treat secondary infections during a pandemic, such as those caused by H1N1 influenza or SARS-CoV-2, and in treating…

Abstract Bacteriophages infect and replicate inside a bacterial host as well as serve as natural bio-control agents. Phages were once viewed as nuisances that caused fermentation failures with cheese-making and…

A new report by British members of parliament (MPs) is calling on the UK government to address issues hampering research and development of bacteriophage therapy. Interest in phages, which are viruses that…

New publication from Lee et al. on "Phage therapy in Korea" Abstract Background Concerns about the rise in antimicrobial resistance have led to renewed interest in phage therapy worldwide, but…

Eastern Bloc countries and the Soviet Union use bacteriophage (phage) therapy for bacterial infections. In the United States, phage is only available in compassionate use scenarios, so there is a…

An interesting article "An outermembrane determinant for RNA phage genome entry in Pseudomonas aeruginosa" by Bae et al., in iScience. Read here: https://doi.org/10.1016/j.isci.2023.108675 SUMMARY: Host range of a phage is determined…

Interaction of Bacteriophages with the Immune System: Induction of Bacteriophage-Specific Antibodies Abstract In all cases when a bacteriophage makes a direct contact with a mammalian organism, it may challenge the…